Rodney H. Falk, MD | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to People / Healthcare Professionals
Rodney H. Falk, MD

Rodney H. Falk, MD

Healthcare Professional
Director
Cardiac Amyloidosis Program
Brigham and Women's Hospital
75 Francis Street
Boston, Massachusetts, United States
Dr. Rodney H. Falk is the Director of the Cardiac Amyloidosis Program and a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH). He is also an associate professor of medicine at Harvard Medical School.
 
Dr. Falk received his medical degree from the University of Birmingham Medical School in the United Kingdom. He then completed three residencies: an internal medicine program at Brook General Hospital, an internal medicine program at City Hospital and a cardiology program at King’s College Hospital, all in London. He also completed a cardiology fellowship at Harvard School of Public Health.
 
Dr. Falk is board certified in internal medicine and cardiovascular disease. He is the author of over 100 peer-reviewed publications, Dr. Falk’s research focuses on understanding cardiac amyloidosis and treatment of this rare disease. His research has been supported by the National Institutes of Health.
 
Dr. Falk’s speciality is cardiovascular medicine and his interests mainly include adult cardiology, anticoagulation, arrhythmias, cardiac amyloidosis, cardiac sarcoidosis,  cardiomyopathy etc.
 
 
Representative Publications:
 
view profile

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close